This highly informative session discusses which companies should and should not seek to become publicly traded. It also imparts insight into the costs of going public and remaining public. A variety of paths a private company can take to become a public company are thoroughly explored. The following are among the issues discussed during this session:
Guest Speaker: Andrea Cataneo is a partner in MSK's Corporate & Business Transactions Practice Group in the firm's New York office. She is also a member of the Capital Markets & Securities as well as its Crypto Assets & Blockchain Technology team. Andrea’s practice focuses on preparing companies for capital raises, structuring secured and unsecured equity and debt financing transactions for early and late stage companies, and taking private companies public via self-registration statements and IPOs.
Andrea represents publicly held companies with respect to 1934 Act reporting obligations to the Securities and Exchange Commission. She performs a variety of corporate transactions for her clients, including mergers and acquisitions, joint ventures, proxy contests, restructurings and corporate governance, NASDAQ and NYSE-American listing applications and all related compliance matters. Her practice covers domestic and international transactions, and she has been active in Italy, Mexico, Argentina, Canada, China, Israel and Kenya. Andrea has also been a leading voice in the Cannabis space, helping private and public clients navigate the developing legal landscape.
